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Effects of maternal hormones may adaptively adjust offspring development to prevailing conditions.
However, Darwinian ﬁtness of parents is maximized by investing in more than one offspring while each
individual offspring beneﬁts from receiving maximal investment. The control of mother and offspring
over hormone-mediated maternal effects is thought to play a key role in the outcome of parent–offspring
conﬂict, but these control mechanisms have hardly been studied.
We investigated the potential embryonic control by analysing the changes in distribution and metab-
olism of steroid hormones in the egg during the ﬁrst 6 days of incubation using injections of radiolabelled
testosterone and corticosterone in freshly laid eggs. After 1 day of incubation the highest amount of
radioactivity was concentrated in a small area at the top of the yolk. This challenges the use of hormones
in oil as mimicking natural exposure. During incubation radioactivity spread within the egg with highest
concentrations in yolk and yolk sac and lower concentrations in albumen, embryo, allantois, and amnion.
Steroids were metabolised to other unconjugated and conjugated steroids, perhaps facilitating embryonic
steroid uptake. Our study shows that the injected radiolabel is metabolised in the egg and taken up by the
embryo, giving the embryo potential control over the effects of maternal hormones and thereby limiting
maternal control over the outcome of hormone-mediated maternal effects.
 2009 Elsevier Inc. All rights reserved.1. Introduction
Vertebrate embryos are exposed to substantial amounts of ste-
roid hormones from their mother. Birds offer excellent models to
study the mechanism and function of these hormone-mediated
maternal effects since the embryo develops outside the mother’s
body, facilitating measurement andmanipulation of early hormone
exposure. Over the last decade there has been a surge in interest in
the role of steroid hormones in avian yolk. The levels of these hor-
mones in the egg vary bothwithin- and between clutches in relation
to a range of factors, such as position in the laying order, food avail-
ability, season, quality of themale or density and social interactions
and have both short- and long-lasting effects on offspring develop-
ment (Gil, 2003, 2008; Groothuis et al., 2005; Groothuis and
Schwabl, 2008;Moore and Johnston, 2008; von Engelhardt and Gro-
othuis, 2005). These ﬁndings have led to the hypothesis that by the
modiﬁcation of yolk hormone levels offspring development can be
adaptively adjusted to prevailing conditions.
If we assume that the effects of hormones in the yolk indeed
have an adaptive function and are not just an epiphenomenon ofll rights reserved.
oural Biology, University of
y. Fax: +49 521 106 2998.
elhardt).production of hormones for the maternal circulation, this raises
the question, whether the effects of yolk hormones of maternal ori-
gin are adaptive for the mother or the offspring. While parents
often beneﬁt from more equal distribution of resources over more
than one offspring, each individual offspring will beneﬁt from
obtaining a higher share of parental investment. Although mater-
nal hormones may be signals rather than resources, they affect
resource distribution by parental investment via affecting rate of
development, begging behaviour, growth and sibling competition.
It is often implicitly assumed that the embryo is only a passive
receiver of the hormonal signals of the mother, providing the
mother the upper hand in the parent–young conﬂict (Schwabl,
1993), but evolution might have provided the embryo with some
degree of control or ﬂexibility in the response mechanisms (Carere
and Balthazart, 2007; Groothuis and Schwabl, 2008; Müller et al.,
2007). A similar, but even more complex situation is discussed in
the context of potential parent–offspring conﬂict in mammals
regarding the effects of hormones produced by mother, placenta
and offspring (Haig, 1993, 1996).
First, to exert an effect on offspring, hormones deposited into
the egg before onset of embryonic development have to be taken
up by the developing embryo. To date it is unclear how the highly
lipophilic steroids are extracted from the yolk by the embryo
(Moore and Johnston, 2008), In addition, the dynamics of the distri-
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different yolk layers contain different concentrations of steroids
(Elf and Fivizzani, 2002; Groothuis et al., 2005).
Second, in order to respond to the maternal hormones the
embryo needs to express receptors and establish physiological
pathways (second messengers, DNA binding sites, etc.) that can re-
sult in an effect of the hormones on gene expression or non-geno-
mic modulation of embryonic physiology. Indeed, the presence of
steroid hormone receptors by day 4 has been demonstrated
through detection of mRNA of androgen and oestrogen receptors
(Smith et al., 1997; Andrews et al., 1997; Endo et al., 2007) and
immunohistochemically using antibodies against progesterone
receptor (Guennon et al., 1987) or oestrogen receptor (Andrews
et al., 1997). Since this occurs before embryonic differentiation of
the gonads and before endogenous steroids are detected (see
Bruggeman et al., 2002) it is possible that receptor expression at
this stage is an adaptation to maternal steroids.
Third, the embryo may produce hormone-metabolising
enzymes that inactivate or modify the activity of maternal hor-
mones. Enzymes or the mRNA for enzymes that convert steroids
have been detected as early as day 2 of incubation (Nomura
et al., 1999; Woods and Weeks, 1969). Parsons (1970) found that
testosterone is clearly metabolized by day 2 blastoderm to mainly
5-b-reduced androgens. He was interested in these reduced andro-
gens, since it had earlier been found that they control haemoglobin
and porphyrin formation (Irving et al., 1976; Levere et al., 1967).
Parsons even speculated about maternal steroids as a source for
these metabolites. However, this suggestion has not been followed
up and it is still unclear whether these metabolites derive from ste-
roid hormones of maternal origin. The metabolism of corticoste-
rone, the main embryonic corticosteroid has not been studied to
our knowledge, but cortisol, one of the corticosteroids produced
by chicken embryos from about day 9 (Kalliecharan and Hall,
1974) is converted in vitro primarily to 20-b-dihydrocortisol by
the chorioallantoic membrane of 6- to 7-day-old embryos (McNatt
et al., 1992). It would therefore be interesting to study whether
maternal cortisol is present in the egg.
Unfortunately there are so far no studies of these control mech-
anisms in birds. A recent study very similar to ours using turtle
eggs (Paitz and Bowden, 2008) found that radioactive oestradiol
administered to the shell at laying was recovered in albumen
and yolk, but not in the embryo within a few days of incubation
and was converted to more polar compounds by enzymes that
could be detected in the yolk, extra-embryonic membranes and
the embryo but not the albumen. This study suggested conversion
of steroids to water-soluble forms would help the transport of the
hormone to the embryo.
In our study, we focused on the distribution, uptake and metab-
olism of steroid hormones from the yolk by the developing
embryo. To this end we injected radiolabelled testosterone and
corticosterone into freshly laid chicken eggs, incubated them for
1, 3 or 6 days and looked at the distribution of radioactivity in
the different compartments of the egg and used thin layer chroma-
tography for investigating the presence of different metabolites.
We used testosterone and corticosterone, because these hormones
have received the most interest so far in the ﬁeld of avian maternal
hormones and have clear and strong effects on embryonic develop-
ment with long-lasting consequences.2. Material and methods
2.1. Injections and incubation
We used three eggs for each hormone treatment and incubation
time and therefore refrained from statistical analysis. Eggs were in-jected and incubated in an incubator that turned eggs every 6 h by
ca. 90 C. Eggs were placed lying on their side, i.e., with the long
axis horizontally, mimicking its natural position in a nest Under
these conditions, due to the lower density of the embryo the yolk
always turns so that the embryo is on its top. We therefore use this
asymmetry to refer to top/up for the side of the egg where the em-
bryo develops and bottom/down as the opposite side, while the
blunt and pointed end of the eggs face sideways. For the injection,
a small hole was drilled through the shell from the side in the mid-
dle of the long axis and about one-third from the top into freshly
laid chicken eggs, which were then injected with ca. 64 kBq
(2 lCi) of radiolabelled testosterone or 33 kBq (1 lCi) corticoste-
rone in 50 ll sesame oil using a Hamilton syringe. For an average
60 g chicken egg this would result in a concentration of ca 1 Bq/
mg (testosterone) or 0.5 Bq/mg (corticosterone) assuming even
distribution over the whole egg (or, since maternal hormones are
mostly found in the yolk, ca. 3 Bq/mg yolk (testosterone and
1.7 Bq/mg yolk (corticosterone) based on an average 20 g yolk).
This is equal to ca. 0.06 pg/mg for both testosterone (speciﬁc activ-
ity ca. 5.1 TBq/mmol and molecular weight 288.43 g/mol) and cor-
ticosterone (speciﬁc activity ca. 3.1 TBq/mmol and molecular
weight 346.46 g/mol). This equals about one-tenth of average tes-
tosterone levels of ca. 0.5 pg/mg measured in chicken yolk (Elf and
Fivizzani, 2002) and much less than reported levels of corticoste-
rone ranging between ca. 1.4 (Eriksen et al., 2003) and ca. 20 pg/
mg (Rettenbacher et al., 2005), However, it should be noted that
very little if any corticosterone may be present in avian eggs be-
cause immunoassays may primarily measure other substances that
cross-react with the antibodies used (Rettenbacher et al., 2005).
Eggs were incubated for 1, 3 or 6 days at 37 C and 50–70% rel-
ative humidity with their long axis horizontally and then frozen in
the same position at 20 C with the upper part marked for orien-
tation purposes. Unfortunately, no embryo, extraembryonic tissue
or blood vessels were visible in 3 day incubated eggs injected with
testosterone, which may have been due to early embryonic death
or infertility, but most likely not due to the treatment since all cor-
ticosterone-treated eggs and 6 day incubated eggs contained
embryos.
2.2. Separation of eggs
Eggs were separated in a cold room (ca. 10 C) by slowly thaw-
ing the eggs until they could be cut and separated in different com-
ponents. If necessary, samples were (temporarily) placed on ice or
dry ice to slow or stop the thawing process. Eggs were separated as
described below depending upon the number of days of
incubation.
2.2.1. One day incubated eggs
With the help of the mark on the top of the egg the eggs were
oriented so that the part with the developing embryo would be
on top. The shell of the egg was removed and a disk of about
5 mm thickness was cut transversely through the middle of the
yolk from top to bottom. This slice was subsequently cut from
top to bottom in three about equally wide sections and the middle
section again cut horizontally into ﬁve approximately equally large
parts of yolk plus the albumen at the top and the albumen at the
bottom of the egg (see Fig. 1, left drawing).
In all testosterone-treated eggs and two of the three corticoste-
rone-treated eggs a small area of lighter coloured material (ca.
4 mm in diameter) could be identiﬁed embedded in the upper part
of the yolk at the border between yolk and albumen. This droplet
was in the same area where we would also expect the developing
embryo, but we could not see the latter in the partially thawed day
1 eggs. We assumed this droplet was the injected oil containing la-
belled steroid, which was conﬁrmed during analysis, because of
Fig. 1. Distribution of radioactivity in becquerel/mg of sample (mean and standard deviation) in a vertical transect of the egg for (a) testosterone and (b) corticosterone,
showing the different egg components schematically, not in relation to their true size. In eggs incubated for 6 days, yolk could be separated in an upper thin yolk and a lower
thick yolk corresponding approximately to the upper and lower part of the yolk shown.
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moved and analysed separately, although it could not be clearly
separated from the surrounding material and was mixed with
some adjacent yolk, sub-embryonic ﬂuid and/or albumen.
2.2.2. Two days incubated eggs
The shell was removed and the embryo on top of the yolk was
carefully removed. For all testosterone-treated eggs (which
contained no visible embryo) we could also still identify the
presumed oil droplet and analysed it separately. Tissue and blood
vessels of the yolk sac were removed from the yolk. A disk was
then cut as for day 1 eggs, except that the smaller central section
was only cut into an upper, middle and lower part (Fig. 1, middle
drawing).
2.2.3. Six days incubated eggs
Again the shell was removed and the embryo removed from the
top of the egg. The embryo was rinsed with 0.9% NaCl. The amnionwas opened and the amniotic liquid collected. The allantois was
separated from the embryo and the yolk sac tissue including blood
vessels was removed from the yolk. Again a disk was cut through
the middle of the egg, the middle section cut and separated in an
upper and a lower part and albumen from above and below the
yolk (Fig. 1, right drawing).
For all eggs, the remaining albumen and yolk was separated and
collected to be used for extraction and thin layer chromatography.
In 6 days incubated eggs, the yolk consists of two parts that can be
easily separated: a lower part that resembles the yolk in fresh eggs
and where the yolk rings are still visible (thick yolk) and an upper
part directly below the embryo and covered by the yolk sac mem-
brane which is more watery, due to uptake of water from the albu-
men (thin yolk or sub-embryonic ﬂuid) (New, 1956; Romanoff,
1943).
All tissue samples (embryo, yolk sac, amnion, allantois) were
weighed (between 3.9 and 1642 mg, depending upon the type of
sample) and homogenized using a sonicator while keeping the
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Yolk and albumen samples were homogenized either also using a
sonicator or by the addition of some glass balls and vortexing.
Up to 2 ml of water was added for homogenization for either very
small or very dense samples and for rinsing of the sonicator to re-
duce losses of samples.
2.3. Scintillation counting
A small aliquot (between 50 and 500 ll, depending upon the
size of the sample) of each homogenized sample was mixed with
scintillation ﬂuid (Ultima Gold, Perkin–Elmer) and analysed on a
Liquid Scintillation Analyzer (Perkin–Elmer) and counts converted
to becquerel using the tSIE method with an external standard and a
quench correction curve made with egg yolk. Results are expressed
per milligram of sample.
2.4. Extraction
The remainder of the homogenates (ca. 1–4 ml) was extracted
3 times with 2 volumes of diethyl ether to extract the apolar
(mostly free) from the polar (mostly conjugated) steroids. An ali-
quot of the residual polar phase (between 100 and 200 ll) was
counted to estimate the proportion of conjugated steroids. Ether
extracts were dried, re-dissolved in 70% methanol and frozen
over night at 20 C to precipitate polar lipids that could inter-
fere with the chromatography. Samples were centrifuged, the
supernatants dried at 45 C under a stream of nitrogen and re-
dissolved in 50 ll ethyl acetate. Ten microlitres of this sample
was counted to estimate the proportion of free steroids, the
remaining 40 ll was used for thin layer chromatography (see be-
low). All radioactivity lost during the extraction in the methanol
precipitates, by absorption to the glass, or in other ways is in-
cluded in the unaccounted fraction. Egg yolk, albumen and tissue
are a complex matrix of proteins and lipids, so that, a clean and
complete extraction of various metabolites with different physi-
cochemical properties is difﬁcult to obtain so that large losses
during the required clean-up procedures for chromatography
are usual.
2.5. Thin layer chromatography and autoradiography
Samples in ethyl acetate were spotted onto a thin layer chro-
matography plate (Sigma, containing a ﬂuorescence indicator)
about 1 cm from the bottom of the plate and with about 1 cm
distance between successive samples. Unlabeled (ca. 1 lg) and
labelled standards (progesterone, androstenedione, testosterone
and corticosterone) were spotted as standards at the side and in
the middle of the plate. Some test-plates were also run under
the same conditions with additional unlabelled standards which
moved up in the following order (upper, fastest moving ﬁrst):
5-a-androstanedione > progesterone > 17-b-estradiol > 5-a-dihydro-
testosterone > androstenedione > 5-b-dihydrotestosterone > tes-
tosterone > corticosterone > cortisol. The plates were developed by
dipping them horizontally for varying amounts of time into solvent
at the bottom of a container. The plates were dipped once into
100% methanol until the solvent front had moved up about
1.2 cm to concentrate the samples into a small zone. Then the
plates were dipped into ethyl acetate:cyclohexane (1:1) until the
solvent front had moved up about 7–12 cm. Separation of the unla-
belled steroid standards was ascertained by their absorption of the
ﬂuorescence from the plate under UV-light. The plates were ex-
posed for several days to a phosphor screen (Packard: type TR, tri-
tium sensitive) and the latent image was detected using a Cyclone
storage phosphor system (Perkin–Elmer).3. Results
3.1. Distribution of radioactivity in the egg
After 1 day of incubation, highest concentrations of radioactiv-
ity were found in both hormone treatments in the upper area of
the yolk, where the embryo develops and where the oil droplet
moved to after injection (Fig. 1). Lower concentrations were found
in the yolk directly below the droplet. Only very low or background
levels of radioactivity were detected in the lower half of the yolk
and the albumen.
After 3 days of incubation most radioactivity was found in the
upper part of the yolk. We only detected embryos in eggs injected
with corticosterone and we found some radioactivity in the yolk
sac tissue, the embryo, amnion and albumen in the upper part of
the egg, indicating hormone uptake by the embryo.
After 6 days of incubation, radioactivity was further distributed
in the egg but the highest concentrations were still found in the
yolk directly below the developing embryo and in the yolk sac
membrane. Lower amounts were measured in the embryo and
albumen and the lowest concentrations in lower part of the yolk,
amnion and allantois.
3.2. Proportions of free and conjugated steroids
Fig. 2 shows that for all tissues and both hormones the apolar
fraction decreased rapidly with days of incubation. The polar frac-
tion containing presumably mostly conjugated steroids increased
rapidly with incubation. Relatively large amounts of radioactivity
of the original sample homogenates were not recovered in some
extracts presumably because parts of the samples stuck to the
sample tubes after extraction and drying and could not be re-dis-
solved and/or because they were contained in the methanol pre-
cipitates. Since this unaccounted radioactivity was extracted by
ether from the homogenates it was probably mostly part of the
apolar fraction.
3.3. Thin layer chromatography of free steroids
The fraction extracted with diethyl ether, containing the free
(including potentially unmodiﬁed injected) hormones was sepa-
rated on thin layer chromatography. For testosterone injected eggs
we found the following: Already after 1 day of incubation at least
one metabolite could be observed in the upper area of the egg, both
in the yolk and the albumen, where the highest concentrations of
radioactivity were measured and where the developing embryo
would be expected (Fig. 3a). Its position indicates this metabolite
could be androstenedione, but further veriﬁcation is required since
the resolution of the thin layer chromatography does not exclude
the possibility that other testosterone metabolites may be found
at the same position. No metabolites were observed in the lower
yolk areas. After 3 and 6 days of incubation several metabolites
were observed in all egg components analysed while after 6 days
there was still only one compound at the expected position of tes-
tosterone in the lowest part of the yolk, suggesting no metabolism
in this area.
For corticosterone injected eggs (Fig. 3b), no metabolism was
observed after 1 day of incubation, except perhaps a more polar
compound in the area where the embryo would develop and where
highest concentrations of radioactivity were observed. After 3 days
all radioactivity was still observed in the position of corticosterone,
except for amniotic ﬂuid where no radioactivity was observed at
the position of corticosterone but at a lower position, suggesting
a very polar metabolite, that moved only very little from the origin
(the origin is the location where the sample was applied and can be
Fig. 2. Proportion of apolar (presumably mostly free) and apolar (presumably mostly conjugated) metabolites for (a) testosterone and (b) corticosterone in proportion of the
total radioactivity of homogenates. Relatively large amounts of radioactivity in some fractions remained unaccounted presumably because the samples were sticking to the
tubes after drying and could not be completely redissolved.
N. von Engelhardt et al. / General and Comparative Endocrinology 163 (2009) 175–183 179seen as the lowest dark spot in some standard lanes, an impurity
that did not move from the origin). In eggs incubated for 6 days
we observed radioactivity both at the position of corticosterone
and more polar compounds.
4. Discussion
In the ﬁeld of hormone-mediated maternal effects it is often as-
sumed that the embryo acts as a passive receiver of the maternal
hormones. However, in the light of parent–offspring conﬂict, the
evolutionary optimum for the hormone effects on the offspring
may be different for parents and offspring (Groothuis and Schwabl,
2008; Müller et al., 2007). Therefore we studied to what extent the
embryo may play an active role in this conﬂict by investigating
embryonic response mechanisms to the maternal hormone expo-
sure. In addition, we analysed the distribution and uptake of in
ovo injections of hormones, that may have important repercussions
for manipulation and measurement of maternal hormones (Gro-
othuis and von Engelhardt, 2005; von Engelhardt and Groothuis,
2005). We focused on testosterone and corticosterone which have
attracted most attention in research on maternal hormones, since
they have strong effects on offspring development and phenotype.
It has to be noted, however, that only the presence of testosterone
and other androgens in yolk has so far been clearly conﬁrmed using
mass spectrometry, while so far all studies on corticosterone haverelied on immunoassays that may detect structurally similar sub-
stances other than corticosterone (Rettenbacher et al., 2005). The
biological relevance of our ﬁndings regarding corticosterone de-
pends therefore on its natural endogenous presence in eggs.
4.1. Distribution dynamics and potential consequences
After 1 day of incubation the radioactivity was highly concen-
trated in the upper area of the yolk and usually the oil droplet
was still visible as a lighter coloured droplet within the yellow
yolk. Since the label was injected into the middle of the yolk, this
shows that the oil droplet with the label moves upwards due to
the lower density of sesame oil compared to yolk. This is consistent
with earlier studies that injected eggs with a coloured substance
dissolved in oil (Walker, 1967). This result suggest that in many
studies in which eggs have been injected with hormones the blas-
toderm, being on top of the yolk, may have been exposed to phar-
macological levels of the hormone, despite scaling the injection
dose to the total amount of hormone in the yolk of eggs of that spe-
cies. Moreover, since the yolk layers differ in hormone concentra-
tions and may be taken up at different times in development,
such a bolus of hormone may not mimic the natural distribution
of the hormone in eggs at all.
However, there are two reasons why hormone injections in
ovo may be less artiﬁcial than suggested above so that manip-
Fig. 3. Examples for separation of the apolar (free) fraction on thin layer chromatography. Samples and standards (S) are applied at the bottom of the plates and eluted from
bottom to top. The least polar substances move fastest, the position of labelled standards is indicated to the right of the standards as follows: P (progesterone), A4
(androstenedione), T (testosterone) and C (corticosterone). The lowest spot seen in some standard lanes is an impurity at the location where the samples were applied. Egg
components are indicated by letters as follows: O (oil droplet), Y (yolk), A (albumen), F (sub-embryonic ﬂuid), YS (yolk sac), TY (thin yolk), AF (amniotic ﬂuid). Samples: (a)
Testosterone: 1 day incubated: S: standard, 1, 2: oil droplet at upper border of yolk and albumen; 3: albumen; 4, 5, 6: yolk with increasing distance from blastoderm. 3 days
incubated: S: standard; 7: highly concentrated label at upper border of yolk and albumen; 8: albumen; 9, 10: sub-embryonic ﬂuid; 11: yolk. 6 days incubated: 12: albumen;
13: yolk sac membrane; 14: thin yolk; A4: androstenedione-standard; S: standards; 15: yolk. (b) Corticosterone: 1 day incubated: S: standards; 1: oil droplet at upper border
of yolk and albumen; 2: albumen; 3, 4: yolk with increasing distance from blastoderm. 3 days incubated: S: standards; 5, 6: yolk; 7: albumen; 8: yolk; S: standards; 9, 10, 11:
amniotic ﬂuid. 6 days incubated: S: standards; 12: albumen; 13: yolk sac membrane; 14: thin yolk; 15: albumen; 16: yolk.
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mone concentrations. First, the blastoderm is not always exactly
on top of the yolk so that it may not always come in direct
contact with the oil droplet. Second, in the course of early incu-
bation the hormone spreads out within the egg in the upper
thin yolk that is formed by mixing of yolk with water from
the albumen resulting also in dissolution of the droplet and
dilution of the initially highly concentrated hormone. Only the
lower thick yolk retains the layered structure so that hormones
are probably released successively here at the time of yolk up-
take of particular layers. Third, since the developing blastoderm
is separated from the yolk by the sub-embryonic ﬂuid (New,
1956; Romanoff, 1943), which consists mainly of water being
therefore very polar, it is likely that at least the free steroids
will diffuse much more easily into the yolk than in the direc-
tion of the embryo.
To overcome the problem of artiﬁcial exposure by means of hor-
mone injection, hormones could be injected in different dosages
according to the concentrations in the different layers of the yolk
and the time that that speciﬁc layer is consumed by the embryo.
However, the latter is not yet known, while the possibility exists
that the hormones are not taken up during the process of yolk con-
sumption but are perhaps taken up only after conversion to a
water-soluble form from the watery phase (see also Paitz and Bow-
den, 2008).By day 3 the label had clearly mixed with the yolk. Although la-
bel was still present mostly in the upper yolk area of the egg, lower
concentrations could now be detected in the developing embry-
onic tissues that were visible only for the eggs injected with corti-
costerone. This indicates for the ﬁrst time that the embryo does
take up maternal hormones or metabolites derived from these hor-
mones at early stages of embryonic development.
By day 6, the label is still primarily found in the upper area of
the yolk but also in relatively high concentrations in the yolk sac
tissues, showing that the hormones are continued to be taken up
by the developing tissues. Concentrations in allantois and am-
nion are lower than in the surrounding albumen and in the em-
bryo. Allantois and amnion consist mostly of water so that the
apolar original label would not dissolve well, but by day 6 most
has been converted to more polar metabolites so that uptake
would be expected. But since both allantois and amnion are
growing rapidly during early embryonic development, this might
result in a dilution of the label entering from the embryo, yolk
or albumen. Also for other substances large variation of relative
concentrations due to barriers between embryonic circulation,
allantois and amnion have been observed (ten Busch et al.,
1997).
In conclusion, the radiolabel is spreading during incubation
from the yolk into all other compartments and is taken up by
the developing embryo, but how far different processes, such as
N. von Engelhardt et al. / General and Comparative Endocrinology 163 (2009) 175–183 181diffusion, active uptake and active excretion play a role, remains
to be studied.
4.2. Metabolism
4.2.1. Polar and apolar metabolites
The label was converted during embryonic development to
more polar metabolites. These were presumably mostly conju-
gated steroids, since conjugation increases solubility in water,
but the actual substances were not identiﬁed and further biochem-
ical characterization of the polar substances was out of the scope of
this study. This conversion may explain the rapid decrease in yolk
hormone levels within the ﬁrst days of incubation reported in pre-
vious studies (Bowden et al., 2002; Eising et al., 2003; Elf and Fiviz-
zani, 2002). Steroid metabolism by the embryo and the extra-
embryonic membranes (yolk sac, allantois, amnion, chorion) has
been observed in all species studied so far, in ﬁsh (Antila, 1984;
Piferrer and Donaldson, 1994), amphibians (Antila, 1977), reptiles
(Painter and Moore, 2005; Paitz and Bowden, 2008), birds (Antila
et al., 1984; Parsons, 1970) and mammals (Levitz, 1966). Chick
blastoderm can metabolise steroid hormones in vitro even within
the ﬁrst 2 days after laying (Antila et al., 1984; Parsons, 1970), pro-
ducing both conjugated and free steroids. This early conversion of
radiolabelled hormone would explain the substantial shift in the
fraction of apolar and unaccounted fraction already between day
1 and day 3 under the assumption that the blastoderm in the eggs
incubated for 3 days with testosterone had been alive but not (yet)
produced red blood cells so that the embryo was not visible.
The proportion of conjugates was highest in the yolk sac tissue
and in the thin yolk (sub-embryonic ﬂuid), while there were less
metabolites in the yolk further removed from the developing em-
bryo. Since we would expect that the enzymes would be present
everywhere in the yolk if they are of maternal origin, this suggests
that the enzymes producing the metabolites are produced by
embryonic tissues rather than of maternal origin. We therefore
think that the metabolites in eggs that were incubated for 3 days
with testosterone and contained no visible embryos were pro-
duced by embryos that died very early in development rather than
by enzymes of maternal origin although we can currently not ex-
clude this possibility.
In turtles, Paitz and Bowden (2008) found enzymatic activity
that could convert free steroids into sulfonated conjugates in yolk
and embryo but not in the albumen. This suggests that the increase
in polar metabolites in the albumen is not due to enzymes in the
albumen but due to diffusion or transport from the yolk into the
albumen. In both the polar albumen and apolar yolk the propor-
tions of polar and apolar steroids are surprisingly similar, which
may relate to the movement of water from the albumen to the thin
yolk, which could result in transportation of the polar metabolites
from the albumen to the yolk and a decrease in concentration of
the free steroids in the yolk.
Non-ether-extractable metabolites may include sulfates (Paitz
and Bowden, 2008), glucuronides (Yeoh et al., 1996), fatty acid es-
ters (Hochberg et al., 1977) and other conjugates. Steroid conju-
gates are often thought to be an inactive form of steroid that
increases solubility in water and facilitate excretion (Pang et al.,
1994), but conjugates may also be a transport form that can be
converted again to active steroids and moreover, may be active
compounds themselves (Coughtrie et al., 1998) that are somewhat
protected from metabolism by conjugation (Hochberg et al., 1991).
As neurosteroids they may modulate neurotransmitter systems
(Baulieu and Robel, 1990; Compagnone and Mellon, 2000) and
can act as sex pheromones, as studied especially in ﬁsh (Colombo
et al., 1980; van den Hurk and Lambert, 1983). Interestingly, by
converting the free steroids to conjugated forms the embryo mayfacilitate and regulate hormone uptake via the watery phase in
the sub-embryonic ﬂuid.
We did not further analyse metabolites in amnion and allantois,
because until day 6 their size was very small and concentrations of
label much lower than in the other tissues. Previous studies could
not detect in both tissues free or conjugated steroids at any stage
before endogenous hormone production starts (Epple et al.,
1997; Gill et al., 1983).
4.2.2. Different forms of apolar metabolites
In the ether-extractable fraction, containing mostly the free ste-
roids, we found one to several other metabolites after 1 day of
incubation for testosterone and after 3 or more days of incubation
also for corticosterone. The number of different metabolites in-
creased during incubation. Metabolites were mostly found in the
areas close to the developing embryo, i.e., in the upper area of yolk
and albumen, sub-embryonic ﬂuid or thin yolk, amniotic ﬂuid and
yolk sac. No or fewer metabolites were observed in the lower yolk
that probably had not been in contact with embryonic or extra-
embryonic tissues, suggesting again that metabolism occurs only
in active tissues and that mixing or diffusion especially within
the yolk is limited.
We do not know which unconjugated metabolites could be
formed from testosterone, but previous in vitro studies show that
5-b-reduced androgens (Antila et al., 1984; Parsons, 1970) can be
produced even by 48 h old embryos. Aromatase which converts
androgens to estrogens has only been found from day 6 (Haffen
and Cedard, 1967) so that a production of estrogens is unlikely.
The chorioallantoic membrane of 6-day-old chicken embryos
metabolises cortisol (McNatt et al., 1992) to 20-b-dihydrocortisol,
but corticosterone metabolism has not been studied to our knowl-
edge. Further characterization and identiﬁcation of the metabolites
is planned.
Again, the most important question is whether the metabolites
formed are active or inactive compounds. Usually 5-b-reduction is
thought to represent an inactivation pathway, but the same 5-b-re-
duced androgens and progestins that the blastoderm can produce
during early development (Antila et al., 1984; Parsons, 1970) affect
various processes during early embryonic development, such as
blood formation (Irving et al., 1976; Levere et al., 1967), and act
as neurosteroids (Aragones et al., 1991; Viapiano and de Plazas,
1998). Some effects of corticosteroids on embryonic development
may also be mediated by metabolites that are usually considered
inactive since they have no classical glucocorticoid activity. 20-b-
dihydrocortisol is formed by embryonic tissue from cortisol (McN-
att et al., 1992) and has anti-angiogenic activity in chicken em-
bryos as also other corticosteroids and their metabolites (Crum
and Folkman, 1984; Folkman and Ingber, 1987).
5. Conclusion
A bolus injection of steroid hormone dissolved in sesame oil
into the yolk will concentrate near the area where the embryo
develops and subsequently diffuses to other parts of the egg,
including embryonic tissue. After 6 days of incubation the hor-
mone is still not evenly distributed over the yolk, challenging the
widely use of hormone injections in the yolk as mimicking natural
levels of exposure. The hormones are metabolized to other so far
unidentiﬁed compounds but the original compounds appear to re-
main present as well, especially in the remaining parts of the yolk.
In particular, there is a rapid increase in more polar, probably con-
jugated steroids, possibly to help the uptake of steroids by the
developing embryo. Both parent compound and metabolites may
play an important role in early embryonic development by regulat-
ing blood formation during early embryonic development, by act-
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